Computer analysis of interacting dopaminergic and cholinergic control mechanisms in the extrapyramidal system.
暂无分享,去创建一个
[1] B. Costall,et al. Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. , 1972, European journal of pharmacology.
[2] M. Besson,et al. Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons. , 1969, European journal of pharmacology.
[3] L. Pieri,et al. Effects of spreading depression on the turnover of cerebral dopamine. , 1972, European journal of pharmacology.
[4] B. Costall,et al. Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. , 1971, Neuropharmacology.
[5] M. Goldstein,et al. The inhibition of catecholamine biosynthesis by apomorphine , 1970, The Journal of pharmacy and pharmacology.
[6] R. Pertwee. The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice , 1972, British journal of pharmacology.
[7] E. Costa,et al. The influence of monoamine oxidase inhibition on catecholamine synthesis. , 1966, Life sciences.
[8] B. Costall,et al. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents. , 1974, Neuropharmacology.
[9] B. Costall,et al. Mesolimbic involvement with behavioural effects indicating antipsychotic activity. , 1974, European journal of pharmacology.
[10] A. Carlsson,et al. Evidence for a receptor‐mediated feedback control of striatal tyrosine hydroxylase activity , 1972, The Journal of pharmacy and pharmacology.
[11] J. Howes,et al. The effect of Δ9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosomal preparations , 1974 .
[12] S. C. Wang,et al. Effects of intracerebroventricular l-hyoscyamine, ethybenztropine and procaine on cardiac arrhythmias induced in dogs by pentylenetetrazol, picrotoxin or deslanoside. , 1968, International journal of neuropharmacology.
[13] K. I. Melville,et al. Centrally mediated sympathetic cardiovascular responses induced by intraventricular norepinephrine. , 1963, Journal of Pharmacology and Experimental Therapeutics.
[14] W. S. Koski,et al. A systems and control theory approach to dynamic neurotransmitter balance in narcotic addiction and narcotic antagonism. , 1975, Life sciences.
[15] L. Beani,et al. Correlation of brain catecholamines with cortical acetylcholine outflow, behaviour and electrocorticogram. , 1974, European journal of pharmacology.
[16] B. Costall,et al. Modification of amphetamine effects by intracerebrally administered anticholinergic agents. , 1972, Life sciences. Pt. 1: Physiology and pharmacology.
[17] S. Snyder,et al. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain. , 1971, Brain research.
[18] P. Mcgeer,et al. Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. , 1961, JAMA.
[19] A. Parent,et al. Cholinesterasic striatopallidal and striatonigral efferents in the cat and the monkey. , 1970, Brain research.
[20] J. Timsit. [On the cataleptic activity of various derivates of butyrophenone]. , 1966, Therapie.
[21] K. Bhargava,et al. An analysis of central adrenoceptors for control of cardiovascular function , 1972, British journal of pharmacology.
[22] S. Garattini,et al. Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum , 1974, The Journal of pharmacy and pharmacology.
[23] G. Zetler. Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. , 1968, International journal of neuropharmacology.
[24] M. Besson,et al. Increased release of dopane from striatal dopaminergic terminals in the rat after treatment with a neuroleptic: thioproperazine. , 1970, European journal of pharmacology.
[25] E. Bristol. On a new measure of interaction for multivariable process control , 1966 .
[26] K. Bhargava,et al. Interrelation between monoaminergic and cholinergic mechanisms in the hypothalamic thermoregulatory centre of rabbits. , 1974, Neuropharmacology.
[27] C. Chiueh,et al. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo. , 1974, The Journal of pharmacology and experimental therapeutics.
[28] K. I. Melville,et al. Centrally mediated cardiovascular responses to isoprenaline. , 1967, International journal of neuropharmacology.
[29] J. del Río,et al. Further studies on the antagonism of stereotyped behaviour induced by amphetamine. , 1969, European journal of pharmacology.
[30] S. Snyder,et al. Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of Action , 1969, Science.
[31] A. Randrup,et al. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour. , 2009, Acta pharmacologica et toxicologica.
[32] G. Gupta,et al. Role of acetylcholine in central vasomotor regulation. , 1967, Canadian journal of physiology and pharmacology.
[33] H. Ladinsky,et al. Cholinergic-dopaminergic interaction in the striatum: The effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil andD-amphetamine , 1975, Brain Research.
[34] W. W. Baker,et al. Antagonism of intracaudate carbachol tremor by local injections of catecholamines. , 1967, The Journal of pharmacology and experimental therapeutics.
[35] U. Ungerstedt,et al. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. , 1971, European journal of pharmacology.
[36] S. Aquilonius,et al. Cholinergic and dopaminergic mechanisms in Huntington's chorea. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.